December 2018 FDA Recall Drug by Results Rna, Llc
D-0360-2019 - Lack of Sterility Assurance and Incorrect/Undeclared excipient

This Class I drug recall was voluntarily initiated by Results Rna, Llc on December 14, 2018 for the product Drug. The FDA reported the reason for recall as lack of sterility assurance and incorrect/undeclared excipient. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0360-2019

Reason for Recall
Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver
Initiated
12-14-2018
Reported
12-26-2018
Quantity
10,297 bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide within the United States
Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, LLC, 1272 S 1380 W., Orem, UT 84058, UPC 7 9238230723 4

Batch or Lot Expiration Information

Lot# All Lots